Literature DB >> 6213366

Induction of cartilage degradation in experimental arthritis produced by allogeneic and xenogeneic proteoglycan antigens.

T Glant.   

Abstract

A single intra-articular injection of proteoglycan (PG) antigens induced sterile inflammatory response and cartilage degradation in preimmunized rabbits and dogs. Both cell-mediated and humoral immune reactions could be detected against PG antigens in these animals, but there was no response against collagen Type II. The lymphocytes isolated from the inflamed synovial layer proved to be predominantly of T cell type. The cartilage degradation was indicated by the accumulation of IgG and complement in the superficial layer of the articular cartilage. By the diminished number of chondrocytes and by the increased binding of specific antibodies in the ground substance. The results suggest that PG antigens trigger local immune reactions which become self-sustaining by enzymatic exposure of antigenic sites. The anti-PG antibodies are cytotoxic to articular chondrocytes and thus can block the continuous neogenesis of matrix components which may lead ultimately to deterioration of the cartilage. This type of experimental arthritis appears to be a model closely related to rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213366     DOI: 10.3109/03008208209160254

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  9 in total

1.  Cartilage proteoglycans as potential autoantigens in humans and in experimental animals.

Authors:  K Mikecz; T T Glant; E Buzás; A R Poole
Journal:  Agents Actions       Date:  1988-02

2.  Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans.

Authors:  T T Glant; K Mikecz; A R Poole
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

3.  Antigenic profiles of human, bovine and canine articular chondrocytes.

Authors:  T Glant; K Mikecz
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

4.  Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls.

Authors:  N J Goodstone; M C Doran; R N Hobbs; R C Butler; J J Dixey; B A Ashton
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

5.  Appearance and persistence of fibronectin in cartilage. Specific interaction of fibronectin with collagen type II.

Authors:  T T Glant; C Hadházy; K Mikecz; A Sipos
Journal:  Histochemistry       Date:  1985

6.  Localization of antigenic components in proteoglycan aggregate of bovine nasal cartilage.

Authors:  T Glant; G Lévai
Journal:  Histochemistry       Date:  1983

7.  Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls.

Authors:  A K Austin; R N Hobbs; J C Anderson; R C Butler; B A Ashton
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

8.  Cellular immunity to cartilage link protein in patients with inflammatory arthritis and non-arthritic controls.

Authors:  M C Doran; N J Goodstone; R N Hobbs; B A Ashton
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

9.  Anti-TNF-α therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice.

Authors:  Bin Liu; Lianjun Yang; Zhifei Cui; Junchi Zheng; Jincheng Huang; Qinghao Zhao; Zhihai Su; Min Wang; Weicong Zhang; Jinshi Liu; Tingxuan Wang; Qingchu Li; Hai Lu
Journal:  Microbiologyopen       Date:  2019-09-26       Impact factor: 3.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.